Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning

Chemico-Biological Interactions

Volumn 175, Issue 1-3, 2008, Pages 173-179

  Kovarik, Zrinka ^a   Čalić, Maja ^a   Šinko, Goran ^a   Bosak, Anita ^a   Berend, Suzana ^a   Vrdoljak, Ana Lucić ^a   Radić, Božica ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

Antidote; Bio scavenger; Butyrylcholinesterase; Nerve agents; Pretreatment

Indexed keywords

1 (4 HYDROXYIMINOMETHYLPYRIDINIUM) 3 (4 CARBAMOYLPYRIDINIUM); 1 (4 HYDROXYIMINOMETHYLPYRIDINIUM) 4 (4 CARBAMOYLPYRIDINIUM)BUTANE DIBROMIDE; 1,1' (BUTANE 1,4 DIYL)BIS[4 (HYDROXYLIMINOMETHYL)PYRIDINIUM]DIBROMIDE; ACETYLCHOLINESTERASE; ANTIDOTE; ATROPINE; CHOLINESTERASE; K 027; K 048; K 074; NERVE GAS; ORGANOPHOSPHORUS COMPOUND; OXIME; TABUN; TRIMEDOXIME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; CHOLINESTERASE INHIBITION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ERYTHROCYTE; HUMAN; HUMAN CELL; INTOXICATION; LD 50; MALE; MOUSE; NONHUMAN;

ACETYLCHOLINESTERASE; ANIMALS; ANTIDOTES; CHOLINESTERASE INHIBITORS; ENZYME REACTIVATORS; MALE; MICE; MICE, INBRED BALB C; OXIMES; PHOSPHORIC ACID ESTERS; PHOSPHORYLATION; POISONING;

MUS;

EID: 50649114408     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.04.011     Document Type: Article

References (23)

1. Dawson R.M. Review of oximes available for the treatment of nerve agent poisoning. J. Appl. Toxicol. 14 (1994) 317-331
2. Stoiljković M.P., and Jokanović M. Pyridinium oximes: rationale for their selection as causal antidotes against organophosphate poisonings and current solutions for auto-injectors. Arh. Hig. Rada Toksikol. 57 (2006) 435-443
3. Antonijević B., and Stoiljković M.P. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin. Med. Res. 5 (2007) 71-82
4. Clement J.G., Shiloff J.D., and Gennings C. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime against tabun and soman poisoning of mice. Arch. Toxicol. 61 (1987) 70-75
5. MacIlwain C. Study proves Iraq used nerve gas. Nature 363 (1993) 3
6. Nagao M., Takatori T., Matsuda Y., Nakajima M., Iwase H., and Iwadate K. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol. Appl. Pharmacol. 144 (1997) 198-203
7. Čalić M., Lucić Vrdoljak A., Radić B., Jelić D., Jun D., Kuča K., and Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 219 (2006) 85-96
8. Lucić Vrdoljak A., Čalić M., Radić B., Berend S., Jun D., Kuča K., and Kovarik Z. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Toxicology 228 (2006) 41-50
9. Kovarik Z., Čalić M., Šinko G., and Bosak A. Structure-activity approach in the reactivation of tabun-phosphorylated human acetylcholinesterase with bispyridinium para-aldoximes. Arh. Hig. Rada Toksikol. 58 (2007) 201-209
10. Kovarik Z., Čalić M., Bosak A., Šinko G., and Jelić D. In vitro evaluation of aldoxime interactions with human acetylcholinesterase. Croat. Chem. Acta 81 (2008) 47-57
11. Ellman G.L., Courtney K.D., Andres R.M., and Featherstone. New and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
12. Kovarik Z., Bosak A., Šinko G., and Latas T. Exploring active sites of cholinesterases by inhibition with bambuterol and haloxon. Croat. Chem. Acta. 76 (2003) 63-67
13. Šinko G., Bosak A., Kovarik Z., and Simeon-Rudolf V. Structure-inhibition relationships in the interaction of butyrylcholinesterase with bambuterol, haloxon and their leaving groups. Chem. -Biol. Interact. 157-158 (2005) 421-423
14. Šinko G., Čalić M., and Kovarik Z. para- and ortho-Pyridinium aldoximes in reaction with acetylthiocholine. FEBS Lett. 580 (2006) 3167-3172
15. Šinko G., Čalić M., Bosak A., and Kovarik Z. Limitation of the Ellman method: cholinesterase activity measurement in the presence of oximes. Anal. Biochem. 370 (2007) 223-227
16. Reiner E. Inhibition of acetylcholinesterase by 4,4′-bipyridine and its effect upon phosphylation of the enzyme. Croat. Chem. Acta 59 (1986) 925-931
17. Thompson W.R. Use of moving averages and interpolation to estimate median-effective dose. Bacteriol. Rev. 11 (1947) 115-145
18. Weil C.S. Tables for convenient calculation of median-effective dose (LD50 or ED50) and instruction in their use. Biometrics 8 (1952) 249-263
19. Kalász H., Hasan M.Y., Sheen R., Kuča K., Petroianu G., Ludányi K., Gergely A., and Tekes K. HPLC analysis of K-48 concentration in plasma. Anal. Bioanal. Chem. 385 (2006) 1062-1067
20. Ashani Y., Bhattacharjee A.K., Leader H., Saxena A., and Doctor B.P. Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators. Biochem. Pharmacol. 66 (2003) 191-202
21. Kovarik Z., Radić Z., Berman H.A., Simeon-Rudolf V., Reiner E., and Taylor P. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates. Biochemistry 43 (2004) 3222-3229
22. Kovarik Z., Ciban N., Radić Z., Simeon-Rudolf V., and Taylor P. Active site mutant acetylcholinesterase interactions with 2-PAM, HI-6 and DDVP. Biochem. Bioph. Res. Co. 342 (2006) 973-978
23. Odžak R., Čalić M., Hrenar T., Primožič I., and Kovarik Z. Evaluation of newly synthesized monoquaternary pyridinium oximes potency to reactivate tabun-phosphorylated acetylcholinesterase. Toxicology 233 (2007) 85-96